Dosing was a perfectly valid concern before the biomarker results appeared. Sorry if it bored you.
I agree CS has gotten out of touch with what's happening at ACW. That can be remedied.
Of course ILAP is good. If it's equivalent to FDA BTD, that's even better than I thought on reading the initial ILAP announcement.
I'll try not to tag you for publicly available info.
Cheers
II
Ann: Actinogen awarded UK Innovation Passport for Xanamem, page-68
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
-0.001(2.63%) |
Mkt cap ! $100.3M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.9¢ | 3.6¢ | $281.6K | 7.556M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1131058 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 660895 | 6 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |